Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

t(8;21) prior to acute leukemia

R Berger1, J Hillion, D Janvier

  • 1INSERM U 301, Paris, France.

Cancer Genetics and Cytogenetics
|October 15, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells.

Leukemia·2010
Same author

Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity.

Scandinavian journal of immunology·2008
Same author

Re-expression of DNA methylation-silenced CD44 gene in a resistant NB4 cell line: rescue of CD44-dependent cell death by cAMP.

Leukemia·2007
Same author

[IgA-mediated auto-immune haemolytic anaemia revealing a hepatitis C virus infection].

La Revue de medecine interne·2007
Same author

Treatment of refractory erosive oral lichen planus with extracorporeal photochemotherapy: 12 cases.

The British journal of dermatology·2007
Same author

Telomeres and telomerase: Pharmacological targets for new anticancer strategies?

Current cancer drug targets·2006
Same journal

Letter to the editor regarding the article "Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenic and prognostic implications".

Cancer genetics and cytogenetics·2010
Same journal

A novel t(10;12)(q21;p13) involving ETV6 in a patient with acute myeloid leukemia.

Cancer genetics and cytogenetics·2010
Same journal

A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)?

Cancer genetics and cytogenetics·2010
Same journal

Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma.

Cancer genetics and cytogenetics·2010
Same journal

Chromosomal imbalances in urinary bladder paraganglioma.

Cancer genetics and cytogenetics·2010
Same journal

A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.

Cancer genetics and cytogenetics·2010
See all related articles

A specific chromosomal translocation, t(8;21), was observed in a patient with polycythemia vera, indicating it can occur before acute leukemia develops. This finding suggests t(8;21) may be an early event in myelodysplasia.

Area of Science:

  • Hematology
  • Cytogenetics
  • Oncology

Background:

  • Polycythemia vera is a myeloproliferative neoplasm.
  • Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders.
  • Acute myeloid leukemia (AML) is a heterogeneous group of cancers.

Observation:

  • A patient with a history of polycythemia vera developed a t(8;21)(q22;q22) chromosomal abnormality.
  • The translocation occurred without evidence of immature myeloid precursor cell invasion in blood and bone marrow.
  • Molecular analysis confirmed the t(8;21) abnormality was identical to that seen in acute myeloid leukemia.

Findings:

  • The t(8;21) translocation can occur in the context of myelodysplastic syndromes.
  • This chromosomal abnormality was detected in a patient previously treated for polycythemia vera.

Related Experiment Videos

  • The presence of t(8;21) may precede the overt development of leukemia.

    • Implications:

    • The t(8;21) translocation might serve as an early indicator of leukemic transformation in myelodysplastic syndromes.
    • This case highlights the importance of cytogenetic analysis in patients with a history of myeloproliferative neoplasms.
    • Further research is warranted to understand the role of t(8;21) in the progression of myeloid malignancies.